Exercise-induced biphasic increase in circulating NT-proBNP levels in patients with chronic heart failure

被引:3
|
作者
Conraads, Viviane M. A. [1 ]
De Maeyer, Catherine [1 ]
Beckers, Paul [1 ]
Possemiers, Nadine [1 ]
Martin, Manuella [2 ]
Van Hoof, Viviane [3 ]
Vrints, Christiaan J. [1 ]
机构
[1] Univ Antwerp Hosp, Dept Cardiol, B-2650 Edegem, Belgium
[2] Univ Antwerp Hosp, Lab Hormones, B-2650 Edegem, Belgium
[3] Univ Antwerp Hosp, Biochem Lab, B-2650 Edegem, Belgium
关键词
natriuretic peptides; chronic heart failure; exercise;
D O I
10.1016/j.ejheart.2008.06.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Exercise increases natriuretic peptide levels in chronic heart failure (CHF) patients, but the effect is considered minor. We assessed acute and short-term release (< 24 h) of NT-proBNP in CHF patients after a maximal cardiopulmonary exercise test (CPET) and 2 different submaximal training sessions. Methods and results: 102 CHF patients either performed CPET (Group 1), a I It endurance (Group 2) or a combined endurance-resistance training session (Group 3). NT-proBNP concentration was determined before, at exercise cessation and after 18-22 h (Protocol A). In 20 patients, samples were obtained before, at exercise cessation, after 15, 30, 45, 60, 90 min, 2, 3, 4, 5, 6, 12, 22 h (Protocol B). Protocol A: At peak exercise, a 15%, 11% and 17% relative increase (p < 0.001 vs baseline, all 3 groups) was seen, with a return to baseline after 18-22 h. The increase correlated with indicators of more advanced heart failure. Protocol B: A biphasic pattern was derived with a first peak within 1 h of exercise termination and a second peak (39%, 31% and 33% higher than baseline; p < 0.05, all 3 groups) after 4-12 h. Conclusions: The observed biphasic release of B-type natriuretic peptides supports standardization of sampling, taking recent exercise into account. (C) 2008 European Society of Cardiology. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:793 / 795
页数:3
相关论文
共 50 条
  • [21] Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients
    Cortes, Raquel
    Portoles, Manuel
    Salvador, Antonio
    Bertomeu, Vicente
    Garcia de Burgos, Fernando
    Martinez-Dolz, Luis
    Rosello Lleti, Esther
    Climent, Vicente
    Jordan, Alejandro
    Paya, Rafael
    Sogorb, Francisco
    Rivera, Miguel
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (06) : 621 - 627
  • [22] Stability of NT-ProBNP in patients with systolic heart failure
    Jimenez-Navarro, Manuel F.
    Fernandez-Moyano, Maria A.
    Dominguez-Franco, Antonio
    Gomez-Doblas, Juan J.
    Molero, Encarnacion
    Gomez-Hernandez, Gemma
    Morell, Miguel
    de Teresa-Galvan, Eduardo
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (10): : 1075 - 1078
  • [23] GENDER DIFFERENCES IN PLASMA LEVELS AND PROGNOSTIC VALUE OF NT-PROBNP IN CHRONIC HEART FAILURE
    Aimo, A.
    Januzzi, J.
    Vergaro, G.
    Clerico, A.
    Ripoli, A.
    Latini, R.
    Meessen, J.
    Anand, I.
    Cohn, J.
    Gravning, J.
    Ueland, T.
    Nymo, S.
    Brunner-La Rocca, H.
    Bayes-Genis, A.
    Lupon, J.
    De Boer, R.
    Yoshihisa, A.
    Takeishi, Y.
    Egstrup, M.
    Gustafsson, I.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E16 - E16
  • [24] Weight reduction decreases NT-proBNP levels in obsese coronary patients with chronic diastolic heart failure
    Cocco, Giuseppe
    Chu, David
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2007, 3 (02) : 112 - 116
  • [25] NT-proBNP, IGF-I and survival in patients with chronic heart failure
    Petretta, Mario
    Colao, Annamaria
    Sardu, Celestino
    Scopacasa, Franco
    Marzullo, Paolo
    Pivonello, Rosario
    Fontanella, Luca
    de Caterina, Maurizio
    de Simone, Adriano
    Bonaduce, Domenico
    [J]. GROWTH HORMONE & IGF RESEARCH, 2007, 17 (04) : 288 - 296
  • [26] Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients
    Cabre, Anna
    Valdovinos, Pilar
    Lazaro, Iolanda
    Bonet, Gil
    Bardaji, Alfredo
    Masana, Lluis
    [J]. CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [27] Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients
    Anna Cabré
    Pilar Valdovinos
    Iolanda Lázaro
    Gil Bonet
    Alfredo Bardají
    Lluís Masana
    [J]. Cardiovascular Diabetology, 12
  • [28] ECONOMIC EVALUATION OF NT-PROBNP GUIDED THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE
    Lu, X.
    Mao, Y.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A572 - A572
  • [29] Gender differences in plasma levels and prognostic value of NT-proBNP in chronic heart failure
    Aimo, A.
    Januzzi, J. L.
    Vergaro, G.
    Latini, R.
    Anand, I. S.
    Cohn, J. N.
    Gravning, J.
    Brunner-La Rocca, H. P.
    Bayes-Genis, A.
    De Boer, R. A.
    Takeishi, Y.
    Egstrup, M.
    Gaggin, H. K.
    Huber, K.
    Emdin, M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 212 - 212
  • [30] Gender differences in plasma levels and prognostic value of NT-proBNP in chronic heart failure
    Aimo, A.
    Januzzi, J.
    Vergaro, G.
    Latini, R.
    Anand, I. S.
    Cohn, J. N.
    Gravning, J.
    Brunner-La Rocca, H. P.
    Bayes-Genis, A.
    De Boer, R. A.
    Takeishi, Y.
    Eggers, K. M.
    Huber, K.
    Passino, C.
    Emdin, M.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 2125 - 2125